Comparative study of 2 μm laser, holmium laser and transurethral resection for non-muscle invasive bladder cancer

Objective: To compare the efficacy and safety of 2 μm laser, holmium laser and transurethral resection of bladder tumor (TURBT) for the treatment of non-muscle invasive bladder cancer (NMIBC). Methods: From June 2011 to June 2013, 210 patients newly diagnosed with primary NMIBC were randomly divided into conventional TURBT group (n=70), holmium laser group (n=70) and 2 μm laser group (n=70). Operative time, complications, postoperative bladder irrigation, catheterization time, hospitalization time were documented. A 2-year follow收稿日期 (Date of reception):2016–02–25 通信作者 (Corresponding author):彭波,Email: 512424474@qq.com doi: 10.3978/j.issn.2095-6959.2016.04.019 View this article at: http://dx.doi.org/10.3978/j.issn.2095-6959.2016.04.019 2 μm 激光,钬激光和经尿道膀胱肿瘤切除术治疗非肌层浸润性膀胱癌的比较研究 胡洋洋,等 445 膀 胱 肿 瘤 是 泌 尿 生 殖 系 统 最 常 见 的 恶 性 肿 瘤 之 一 , 其 中 非 肌 层 浸 润 性 膀 胱 癌 (n o n m u s c l e invasive bladder cancer,NMIBC)约占75%~85%。 经尿道膀胱肿瘤切除术(transurethral resect ion of the bladder tumor,TURBT)一直被认为是治疗非 肌层浸润性膀胱癌的“金标准”。近年来2 μm激 光、钬激光等相继问世,成为治疗膀胱肿瘤新的 微创技术 。然而目前缺少2 μm激光、钬激光与 传统的TURBT在治疗非肌层浸润性膀胱癌上的随 机对照研究和长期随访研究,是否存在优势尚有 争议。在本研究中,我们将比较2 μm激光、钬激 光和TURBT在治疗NMIBC上的安全性和有效性, 结果如下。